Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis

MLA

Ulrich H. Weidle, et al. “Urokinase-Type Plasminogen Activator (UPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis.” Journal of Obstetrics and Gynaecology, vol. 21, Apr. 1995, pp. 151–65. EBSCOhost, https://doi.org/10.1111/j.1447-0756.1995.tb01089.x.

APA

Ulrich H. Weidle, Hidekazu Ohi, Ute Reuning, Hiroshi Kobayashi, Olaf Wilhelm, Henner Graeff, Nobuhiko Moniwa, Viktor Magdolen, Fritz Jänicke, & Manfred Schmitt. (1995). Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis. Journal of Obstetrics and Gynaecology, 21, 151–165. https://doi.org/10.1111/j.1447-0756.1995.tb01089.x

Chicago

Ulrich H. Weidle, Hidekazu Ohi, Ute Reuning, Hiroshi Kobayashi, Olaf Wilhelm, Henner Graeff, Nobuhiko Moniwa, Viktor Magdolen, Fritz Jänicke, and Manfred Schmitt. 1995. “Urokinase-Type Plasminogen Activator (UPA) and Its Receptor (CD87): A New Target in Tumor Invasion and Metastasis.” Journal of Obstetrics and Gynaecology 21 (April): 151–65. doi:10.1111/j.1447-0756.1995.tb01089.x.